Abterra Biosciences

📍 San Diego, United States🗓 Founded 2009👥 11 employees💰 Last funded Sep 2021
Biotechnology🌐 abterrabio.com
Website LinkedIn
Abterra Bio is enabling the next-generation of antibody therapeutics. Our technologies use the latest in next-generation sequencing, mass spectrometry, and machine learning methods to comprehensively map the antibody response to challenge. We give our partners access to every relevant antibody to meet their project goals. Find out what service might be right for you with our service guide: https://abterrabio.com/service-guide/ Abterra Bio began life as Digital Proteomics LLC, a spin-out of the University of California – San Diego. Founders Pavel Pevzner and Vineet Bafna are professors in the Computer Science and Engineering Department and leading researchers in bioinformatics. Their expertise forms the algorithmic foundation upon which our products and services are built.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
2009
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Abterra Biosciences?
Abterra Biosciences has 2 investors on record on gritt.io.
When did Abterra Biosciences last raise funding?
The most recent investment in Abterra Biosciences recorded on gritt.io was in September 2021.
When was Abterra Biosciences founded?
Abterra Biosciences was founded in 2009.
What industry is Abterra Biosciences in?
Abterra Biosciences operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Abterra Biosciences based?
Abterra Biosciences is headquartered in San Diego, United States.